Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: Availability and outcomes
Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: Availability and outcomes
复制标题
DOI：
10.1016/j.jsat.2006.11.002
复制
发表时间：
2007-06-01
影响因子：
3.9
通讯作者：
Bluthenthal, Ricky N.
中科院分区：
文献类型：
--
作者：
Heinzerling, Keith G.;Kral, Alex H.;Bluthenthal, Ricky N.
我们通过对24名注射器交换计划主任和560名注射器交换客户的采访，描述了加州各地注射器交换计划中人类免疫缺陷病毒(HIV)和丙型肝炎病毒(HCV)检测服务的可用性和结果。62%的项目同时提供艾滋病毒和丙型肝炎病毒检测服务，21%的项目只进行了艾滋病毒检测，17%的项目没有提供这两项服务。由医疗保健/社会服务提供者管理的项目比独立的注射器交换项目更有可能提供艾滋病毒和丙型肝炎检测服务。在提供检测的项目的客户中，非法项目的客户使用注射器交换HIN和丙型肝炎病毒检测服务的可能性明显低于合法项目的客户。在注射器交换计划中提供艾滋病毒和丙型肝炎病毒检测服务的情况各不相同，客户使用现有检测服务的情况并不普遍。需要努力在注射器交换方案中增加艾滋病毒和丙型肝炎病毒检测服务的可获得性，并利用现有的检测服务。(C)2007 Elsevier Inc.保留所有权利。
We described the availability and outcomes of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) testing services at syringe exchange programs throughout California, using interviews with 24 syringe exchange Program directors and 560 syringe exchange clients. Both HIV and HCV testing services were available in 62% of programs, 21% had HIV testing only, and 17% had neither. Programs administered by health care/social service providers were more likely than independent syringe exchange programs to have HIV and HCV testing services available. Among clients of programs with testing available, clients of illegal programs were significantly less likely than clients of legal programs to have used syringe exchange HIN and HCV testing services. The availability of HIV and HCV testing services at syringe exchange programs varies, and the use of existing testing services by clients is not universal. Efforts to increase both the availability of HIV and HCV testing services at syringe exchange programs and the use of existing testing services are needed. (C) 2007 Elsevier Inc. All rights reserved.